Sun Pharmaceutical Industries Limited has informed the Exchange regarding Notice of Postal Ballot for appointment of Ms. Satyavati Berera as an Independent Director
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharma is seeking shareholder approval via postal ballot/e-voting to appoint Ms. Satyavati Berera (former COO of PwC India, age 65) as an Independent Director for a 5-year term. The appointment is to replace Ms. Rama Bijapurkar, the outgoing Woman Independent Director whose term ends on 20 May 2026 (she declined reappointment for personal reasons). The appointment ensures continued compliance with SEBI's requirement for a woman independent director on the board. E-voting runs from 9 April 2026 to 8 May 2026, with results expected by 11 May 2026. An external agency assisted the Nomination and Remuneration Committee in identifying Ms. Berera, citing her strong audit, risk advisory, and governance expertise from a 40+ year career.
Routine board composition change to maintain regulatory compliance and gender diversity. Should be neutral for the stock — Ms. Berera brings strong Big Four audit and risk credentials, which may strengthen board oversight. Shareholders need to vote by 8 May 2026.